Related Experiment Video
Updated: Aug 11, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications
Nira Ben-Jonathan1, Dana C Borcherding2, Eric R Hugo3
1Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio, USA.
Dopamine type 1 receptors (D1R) are overexpressed in breast cancer (BC), promoting tumor growth. Targeting D1R with fenoldopam may offer a new therapeutic strategy for BC patients.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Breast cancer (BC) is a leading cause of cancer death in women, with limited options for advanced, resistant cases.
- Estrogen receptor and HER2 therapies improve outcomes but fail in a subset of patients, necessitating novel treatments.
Approach:
- This review examines the role of dopamine (DA) and its type 1 receptors (D1R) in BC pathogenesis and progression.
- Evidence suggests D1R overexpression in approximately 30% of BC cases correlates with advanced disease and poorer survival.
Key Points:
- D1R activation, signaling through the cGMP/PKG pathway, induces apoptosis, inhibits invasion, and enhances chemosensitivity in BC cells.
- Fenoldopam, a D1R agonist, suppressed D1R-expressing BC xenografts in mouse models.
- D1R may serve as a diagnostic/prognostic marker for BC.
Conclusions:
- Fenoldopam, an FDA-approved drug, shows potential for repurposing as a BC therapeutic agent for D1R-positive tumors.
- Modulators of the cGMP/PKG pathway could also be explored for BC treatment.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways